Leading transformation in clinical development
Speed, simplicity & scalability
Hear the latest insights from our experts on how to leverage one partner for your CRO and CDMO solutions.
It’s about time for clinical research solutions that bring treatments to patients faster, with new technologies that accelerate trials
Explore how to harness this transformational moment in clinical development from experts at the PPD™ clinical research business of Thermo Fisher Scientific.
Integrated, end-to-end clinical development solutions
Sponsors looking to gain speed, simplicity and scalability should look no further than our integrated CRO and CDMO capabilities to streamline the drug development process and enhance better outcomes.
Integrated solutions to accelerate and economize clinical trial development
Expert info
Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific
Collaboration and communication to mitigate risks and accelerate clinical timelines
Expert info
Brenda Bruker, executive director, integrated supply and delivery services, PPD clinical research business of Thermo Fisher Scientific
Bundling CDMO and CRO for speed, simplicity, and scalability in drug development
Expert info
Tanya Momtahen, vice president, customer asset development, PPD clinical research business of Thermo Fisher Scientific
Revolutionizing clinical trials through AI
Artificial intelligence (AI) is disrupting and transforming traditional clinical trial processes. Learn how advancements in the application of AI are breaking down barriers and building more unified workflows.
AI-driven digital transformation enhances speed and efficiency in our industry
Expert info
Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific
Using AI to reduce white space and accelerate clinical trial timelines
Expert info
John Van Hoy, executive director, data science, PPD clinical research business of Thermo Fisher Scientific
Innovative trends in AI-driven drug discovery and protocolized data collection
Expert info
Dr. Pete Wahl, MLA, MS, ScD, vice president, global head of scientific affairs, CorEvitas
AI transforming data monitoring and cleaning in clinical trials: a unified approach
Expert info
John Van Hoy, executive director, data science, PPD clinical research business of Thermo Fisher Scientific
Flexible delivery models
A one-size-fits-all approach doesn’t apply to clinical development. When trials demand flexibility, FSP solutions deliver the expertise you want and the on-time delivery you need.
Flexible FSP solutions offering regulatory, pharmacovigilance, and clinical support
Expert info
Heather Hutsell, director, oversight delivery lead, PPD clinical research business of Thermo Fisher Scientific
Leveraging innovation and mitigating risk
The abundance of new technologies and approaches driving the industry forward can leave drug developers overwhelmed and looking for guidance to determine the best path forward. Our experts help you cut through the noise and determine what’s right for your study and what can be left behind.
Embrace change to accelerate drug development and reduce patient treatment delays
Expert info
Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific
Engage your CRO early to mitigate risks and avoid amendments
Expert info
Tanya Momtahen, vice president, customer asset development, PPD clinical research business of Thermo Fisher Scientific
Embrace AI and digital tools to accelerate development and improve patient care
Expert info
Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific
Maximizing ROI with RWE
With more data being produced, pharmaceutical companies have the opportunity to tap into vast amounts of knowledge to advance their most promising assets. Effective use of real-world evidence is reshaping how sponsors tell their value story.
Using real world evidence to expand indications and develop new drug assets
Expert info
Ariel Berger, executive director, integrated solutions RWE, PPD clinical research business of Thermo Fisher Scientific
Maximize ROI by proactively engaging with unique real world data assets early
Expert info
Dr. Pete Wahl, MLA, MS, SCD, vice president, global head of scientific affairs, CorEvitas
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Using social media and machine learning to enhance patient-centered care
58 seconds
Expert info
Ariel Berger, executive director, integrated solutions RWE, PPD clinical research business of Thermo Fisher Scientific